chr4-73440656-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001134.3(AFP):c.325G>C(p.Gly109Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000365 in 1,614,140 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0017 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 2 hom. )
Consequence
AFP
NM_001134.3 missense
NM_001134.3 missense
Scores
1
8
9
Clinical Significance
Conservation
PhyloP100: 2.79
Genes affected
AFP (HGNC:317): (alpha fetoprotein) This gene encodes alpha-fetoprotein, a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatocarcinoma and with teratoma, and has prognostic value for managing advanced gastric cancer. However, hereditary persistance of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of alpha-fetoprotein in amniotic fluid is used to measure renal loss of protein to screen for spina bifida and anencephaly. [provided by RefSeq, Oct 2019]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.006657034).
BP6
Variant 4-73440656-G-C is Benign according to our data. Variant chr4-73440656-G-C is described in ClinVar as [Benign]. Clinvar id is 742527.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00172 AC: 261AN: 152146Hom.: 2 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
261
AN:
152146
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000549 AC: 138AN: 251488 AF XY: 0.000390 show subpopulations
GnomAD2 exomes
AF:
AC:
138
AN:
251488
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000224 AC: 328AN: 1461876Hom.: 2 Cov.: 31 AF XY: 0.000204 AC XY: 148AN XY: 727236 show subpopulations
GnomAD4 exome
AF:
AC:
328
AN:
1461876
Hom.:
Cov.:
31
AF XY:
AC XY:
148
AN XY:
727236
Gnomad4 AFR exome
AF:
AC:
276
AN:
33480
Gnomad4 AMR exome
AF:
AC:
9
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26134
Gnomad4 EAS exome
AF:
AC:
0
AN:
39696
Gnomad4 SAS exome
AF:
AC:
0
AN:
86254
Gnomad4 FIN exome
AF:
AC:
0
AN:
53420
Gnomad4 NFE exome
AF:
AC:
15
AN:
1112006
Gnomad4 Remaining exome
AF:
AC:
28
AN:
60394
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00171 AC: 261AN: 152264Hom.: 2 Cov.: 32 AF XY: 0.00161 AC XY: 120AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
261
AN:
152264
Hom.:
Cov.:
32
AF XY:
AC XY:
120
AN XY:
74452
Gnomad4 AFR
AF:
AC:
0.00618532
AN:
0.00618532
Gnomad4 AMR
AF:
AC:
0.000130719
AN:
0.000130719
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000147007
AN:
0.0000147007
Gnomad4 OTH
AF:
AC:
0.000473934
AN:
0.000473934
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
35
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
82
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Aug 16, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MutPred
Gain of glycosylation at S111 (P = 0.0575);Gain of glycosylation at S111 (P = 0.0575);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Mutation Taster
=96/4
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at